Event Timeline
| 01:00 PM - 01:10 PM |
|
Introduction
|
| 01:00 PM - 05:00 PM |
Abstract |
001 - SHANK3 Overexpression Causes Manic-like Behavior with Unique Pharmacogenetic Properties
Jimmy Holder, MD
|
| 01:00 PM - 05:00 PM |
Abstract |
001 - Abnormal white matter connectivity in children with autism or sensory processing disorder: overlap and divergence.
Elysa Marco, MD
|
| 01:00 PM - 05:00 PM |
Abstract |
002 - Predictors of Response to Propranolol for Social Functioning in Autism Spectrum Disorder
David Q. Beversdorf, MD, FAAN
|
| 01:00 PM - 05:00 PM |
Abstract |
002 - Delayed low level visual processing in infants with Tuberous Sclerosis Complex (TSC)
Pilar Pichon, MD
|
| 01:00 PM - 05:00 PM |
Abstract |
003 - Cognitive and developmental predictors of ASD in infants with Tuberous Sclerosis Complex.
Shafali Jeste, MD, FAAN
|
| 01:00 PM - 05:00 PM |
Abstract |
003 - Value of routine EEG in Autistic patients w/ stereotypic behavioral movements
Ankit Nayyar, MD
|
| 01:00 PM - 05:00 PM |
Abstract |
004 - Knockout of p75NTR in Cerebellar Purkinje Cells Results in an Autism-like Murine Phenotype
Nina F. Schor, MD, PhD, FAAN
|
| 01:00 PM - 05:00 PM |
Abstract |
004 - High-Functioning Autistic Children Have Abnormal Stapedial Reflexes
Richard Lukose, DO
|
| 01:00 PM - 05:00 PM |
Abstract |
005 - Resting state EEG serves as a promising biomarker of cognitive and language function in young children with ASD.
|
| 01:00 PM - 05:00 PM |
Abstract |
005 - Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders
Matteo Pardini, MD, PhD
|
| 01:00 PM - 05:00 PM |
Abstract |
006 - Behavioral Profiles of Children and Adolescents with Specific Language Impairment and High Functioning Autism
Marisela E. Dy-Hollins, MD, MSCR, FAAN
|
| 01:00 PM - 05:00 PM |
Abstract |
007 - Mean EEG coherence in infants at risk for autism spectrum disorder
April Levin, MD
|
| 01:00 PM - 05:00 PM |
Abstract |
008 - Genetic Animal Models of Autism Based on Shank/ Mutation Molecules to Potential Therapeutics
Craig M. Powell, MD, PhD, FAAN
|
| 01:00 PM - 05:00 PM |
Abstract |
009 - Autistic Symptoms in a Geriatric Population with Mild Cognitive Impairment and Early Dementia
Danielle Crawford
|
| 01:00 PM - 05:00 PM |
Abstract |
010 - Intrinsic Excitability Defects in Specific Subtypes of Medial Prefrontal Cortex Pyramidal Neurons in a Mouse Model of Autism
Audrey C. Brumback, MD, PhD
|
| 01:10 PM - 01:40 PM |
|
Autism Spectrum and Epilepsy Spectrum
Frances E. Jensen, MD, FAAN
|
| 01:40 PM - 02:10 PM |
|
GI and Autism from Research and Clinical Point of View
Kara Gross, MD
|
| 02:10 PM - 02:40 PM |
|
Autism, GI, MET Genes, and Connectivity Theory
Pat R. Levitt, MD
|
| 02:40 PM - 03:10 PM |
|
Mitochondrial Dysfunction, Purinergic Signaling, ASD, and Clinical Trials
Robert Naviaux, MD, PhD
|
| 03:10 PM - 03:30 PM |
|
Questions and Answers
|
| 03:30 PM - 04:30 PM |
|
Poster Rounds
|
| 04:30 PM - 05:00 PM |
|
Data Blitz
|
Faculty Disclosures
| Margaret L. Bauman, MD, FAAN |
No disclosure on file
|
| Martha R. Herbert, MD, PhD |
No disclosure on file
|
| Frances E. Jensen, MD, FAAN |
Dr. Jensen has received research support from Passages Bio. |
| Kara Gross, MD |
No disclosure on file
|
| Pat R. Levitt, MD |
No disclosure on file
|
| Robert Naviaux, MD, PhD |
No disclosure on file
|
| Craig M. Powell, MD, PhD, FAAN |
No disclosure on file
|
| April Levin, MD |
No disclosure on file
|
| Marisela E. Dy-Hollins, MD, MSCR, FAAN |
The institution of Dr. Dy-Hollins has received research support from CNCDP-K12. |
| Danielle Crawford |
No disclosure on file
|
|
No disclosure on file
|
| Jordan S. Dubow, MD |
Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals. |
| Angela Ballantyne, MD |
No disclosure on file
|
| Doris A. Trauner, MD |
No disclosure on file
|
| Daniel Friedman, MD |
The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America. |
| Dale C. Hesdorffer |
No disclosure on file
|
| Gregory A. Jicha, MD, PhD |
Dr. Jicha has nothing to disclose. |
| Shafali Jeste, MD, FAAN |
Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance. |
| Erin Abner |
No disclosure on file
|
| Krai Chatamra, PhD |
No disclosure on file
|
| Paolo Curatolo |
No disclosure on file
|
| Janet Benesh, BSMT |
No disclosure on file
|
| Richard Lukose, DO |
Dr. Lukose has nothing to disclose. |
| Nina F. Schor, MD, PhD, FAAN |
Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director, NINDS with National Institutes of Health. |
| Rebecca Spiegel, MD |
No disclosure on file
|
| Kevin Brown |
No disclosure on file
|
| Elysa Marco, MD |
No disclosure on file
|
| Weining Robieson, PhD |
Dr. Robieson has received personal compensation for serving as an employee of AbbVie. Dr. Robieson has received stock or an ownership interest from AbbVie. |
| Neha Mirchandani, MD |
No disclosure on file
|
| David Q. Beversdorf, MD, FAAN |
Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Human Biosciences. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Stalicla. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scioto. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from BionexusKC. The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $10,000-$49,999 for serving as a Case Consultant with Best Doctors. |
| Ankit Nayyar, MD |
No disclosure on file
|
| Jimmy Holder, MD |
Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical. |
| Pilar Pichon, MD |
Dr. Pichon has stock in Merck. Dr. Pichon has stock in Boston Scientific. Dr. Pichon has stock in Fulcrum therapeutics. Dr. Pichon has stock in Bristol-Myers Squibb. Dr. Pichon has stock in CyromX. Dr. Pichon has stock in Recursion pharmaceuticals. Dr. Pichon has stock in America Well. Dr. Pichon has stock in NanoVicirides. Dr. Pichon has stock in Alzamend Neuro. Dr. Pichon has stock in Synaptogenix. Dr. Pichon has stock in Tyra Biosciences. Dr. Pichon has stock in Teladoc Health. Dr. Pichon has stock in Augmedix. Dr. Pichon has stock in Vaxxinity. Dr. Pichon has stock in Immunogen. Dr. Pichon has stock in Abbott. Dr. Pichon has stock in Roche. Dr. Pichon has stock in Vir Biotechnology. Dr. Pichon has stock in Altamira therapeutics. Dr. Pichon has stock in Talkspace. Dr. Pichon has stock in GE. Dr. Pichon has stock in GE Healthcare. Dr. Pichon has stock in Wolters Kluwer. Dr. Pichon has stock in Doximity. Dr. Pichon has stock in Coherus Biosciences. Dr. Pichon has stock in ABVC Biopharma Inc. Dr. Pichon has stock in AC Immune . Dr. Pichon has stock in Armata Pharmaceuticals. Dr. Pichon has stock in Atea Pharmaceuticals. Dr. Pichon has stock in Bellicum Pharmaceuticals. Dr. Pichon has stock in Evaxion Biotech. Dr. Pichon has stock in Geovax Labs. Dr. Pichon has stock in Atyr Pharma. Dr. Pichon has stock in Neurometrix. Dr. Pichon has stock in Novavax. Dr. Pichon has stock in PROQR Therapeutics. Dr. Pichon has stock in Avidity Biosciences. Dr. Pichon has stock in Surrozen. Dr. Pichon has stock in Takeda. Dr. Pichon has stock in Telesis Bio. Dr. Pichon has stock in Well Health Technologies. |
| David S. Goldstein, MD, PhD |
Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| Audrey C. Brumback, MD, PhD |
No disclosure on file
|
| Paul Morgan |
No disclosure on file
|
| Joyce Y. Wu, MD |
Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. The institution of Dr. Wu has received research support from National Institutes of Health. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. |
| Huda Zoghbi, MD |
Dr. Zoghbi has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TCG. Dr. Zoghbi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cajal Neuroscience. Dr. Zoghbi has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Regeneron. The institution of Dr. Zoghbi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annual Review of Neuroscience . The institution of Dr. Zoghbi has received research support from Ionis. The institution of Dr. Zoghbi has received research support from UCB. Dr. Zoghbi has received intellectual property interests from a discovery or technology relating to health care. Dr. Zoghbi has received publishing royalties from a publication relating to health care. |
| Stefan Nessler, MD |
No disclosure on file
|
| Matteo Pardini, MD, PhD |
No disclosure on file
|
| Mustafa Sahin, MD, PhD |
Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenxbio . Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Centene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for PTEN Research. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Sahin has received research support from NIH. The institution of Dr. Sahin has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sahin has received research support from Charities Aid Foundation. The institution of Dr. Sahin has received research support from Simons Foundation Autism Research Initiative. The institution of Dr. Sahin has received research support from Aucta Pharmaceuticals . The institution of Dr. Sahin has received research support from Loulou Foundation. |
| Bruce A. Cohen, MD, FAAN |
Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. The institution of Dr. Cohen has received research support from Genentech. The institution of Dr. Cohen has received research support from MedDay. The institution of Dr. Cohen has received research support from Consortium of Multiple Sclerosis Centers. |
| Roshan L. Koul, MD, DM, FRCPCH |
No disclosure on file
|
| Timothy Cunniff, PharmD |
Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences. |
| Stephen Wanaski, PhD |
Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences. |
| James M. Meyer, PharmD |
No disclosure on file
|